CK Life Sciences International Holdings Inc
00775
Company Profile
Business description
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D. The company derives maximum revenue from the Nutraceutical segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.
Contact
2 Dai Fu Street
Tai Po Industrial Estate
Tai Po
Hong Kong
HKGT: +852 21261212
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
2,033
Stocks News & Analysis
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
stocks
Bookworm: Is this the secret to exceptional long-term returns?
Acceptance may be an investor’s best friend.
stocks
Unconventional wisdom: Are dividends the answers?
As investors toil in complexity the obvious solution may be the right one.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,959.90 | 25.60 | 0.29% |
| CAC 40 | 7,834.58 | 16.30 | 0.21% |
| DAX 40 | 24,217.50 | 78.43 | -0.32% |
| Dow JONES (US) | 44,901.92 | 208.01 | 0.47% |
| FTSE 100 | 9,120.31 | 18.06 | -0.20% |
| HKSE | 25,526.59 | 138.24 | 0.54% |
| NASDAQ | 21,108.32 | 50.36 | 0.24% |
| Nikkei 225 | 41,141.20 | 315.03 | -0.76% |
| NZX 50 Index | 12,949.96 | 96.50 | 0.75% |
| S&P 500 | 6,388.64 | 25.29 | 0.40% |
| S&P/ASX 200 | 8,694.10 | 27.20 | 0.31% |
| SSE Composite Index | 3,598.15 | 4.49 | 0.12% |